Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan;28(1):16.
doi: 10.1111/iju.14419. Epub 2020 Nov 3.

Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence

Hajime Tanaka  1 , Yasuhisa Fujii  1
Affiliations
Editorial

Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence

Hajime Tanaka et al. Int J Urol. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Nakagawa T. Lymph node dissection for bladder cancer: Current standards and the latest evidence. Int. J. Urol. 2021; 28: 7-15.
    1. Zargar-Shoshtari K, Zargar H, Lotan Y et al. A multi-institutional analysis of outcomes of patients with clinically node positive urothelial bladder cancer treated with induction chemotherapy and radical cystectomy. J. Urol. 2016; 195: 53-9.
    1. Urakami S, Yuasa T, Yamamoto S et al. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol. 2015; 20: 1171-8.
    1. Gschwend JE, Heck MM, Lehmann J et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. Eur. Urol. 2019; 75: 604-11.
    1. Necchi A, Anichini A, Raggi D et al. Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm. Phase-II Study. J. Clin. Oncol. 2018; 36: 3353-60.

LinkOut - more resources